Risks of Cardiac Valve Regurgitation and Heart Failure Associated with Ergot- and Non-Ergot-Derived Dopamine Agonist Use in Patients with Parkinson's Disease: A Systematic Review of Observational Studies.
about
Side effects of a dopamine agonist therapy for Parkinson's disease: a mini-review of clinical pharmacologyThe recommendations of Chinese Parkinson's disease and movement disorder society consensus on therapeutic management of Parkinson's diseaseThe drug treatment of delayed ejaculationParkinson's Disease: From Pathogenesis to PharmacogenomicsStructural and functional alterations of the heart in Parkinson's disease.
P2860
Risks of Cardiac Valve Regurgitation and Heart Failure Associated with Ergot- and Non-Ergot-Derived Dopamine Agonist Use in Patients with Parkinson's Disease: A Systematic Review of Observational Studies.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Risks of Cardiac Valve Regurgi ...... view of Observational Studies.
@en
type
label
Risks of Cardiac Valve Regurgi ...... view of Observational Studies.
@en
prefLabel
Risks of Cardiac Valve Regurgi ...... view of Observational Studies.
@en
P2093
P2860
P1433
P1476
Risks of Cardiac Valve Regurgi ...... view of Observational Studies.
@en
P2093
Christel Renoux
Samy Suissa
Tanja Tran
P2860
P2888
P304
P356
10.1007/S40263-015-0293-4
P577
2015-11-19T00:00:00Z